Page last updated: 2024-10-15

acetylcarnitine and Ureteral Obstruction

acetylcarnitine has been researched along with Ureteral Obstruction in 1 studies

Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, DQ1
Cao, G1
Chen, H1
Argyopoulos, CP1
Yu, H1
Su, W1
Chen, L1
Samuels, DC1
Zhuang, S1
Bayliss, GP1
Zhao, S1
Yu, XY1
Vaziri, ND1
Wang, M1
Liu, D1
Mao, JR1
Ma, SX1
Zhao, J1
Zhang, Y1
Shang, YQ1
Kang, H1
Ye, F1
Cheng, XH1
Li, XR1
Zhang, L1
Meng, MX1
Guo, Y1
Zhao, YY1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714]Phase 1/Phase 260 participants (Anticipated)Interventional2023-11-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for acetylcarnitine and Ureteral Obstruction

ArticleYear
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
    Nature communications, 2019, 04-01, Volume: 10, Issue:1

    Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea

2019